John Desjarlais

Person

Pasadena, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Heterodimeric antibodies that bind fibroblast activation protein
- Patent number 12,180,302
- Issue date Dec 31, 2024
- Xencor, Inc.
- John Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific and monospecific antibodies using novel anti-PD-1 sequences
- Patent number 12,152,076
- Issue date Nov 26, 2024
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alp...
- Patent number 12,139,525
- Issue date Nov 12, 2024
- Xencor, Inc.
- Matthew J. Bernett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Heterodimeric antibodies that bind CD3 and CD38
- Patent number 12,129,309
- Issue date Oct 29, 2024
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Engineered IL-2 Fc fusion proteins
- Patent number 11,981,717
- Issue date May 14, 2024
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 11,945,880
- Issue date Apr 2, 2024
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PD-1 targeted IL-15/IL-15Rα Fc fusion proteins with improved proper...
- Patent number 11,932,675
- Issue date Mar 19, 2024
- Genentech, Inc.
- John Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fc variants with altered binding to FcRn
- Patent number 11,932,685
- Issue date Mar 19, 2024
- Xencor, Inc.
- Aaron Keith Chamberlain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD28 compositions
- Patent number 11,919,958
- Issue date Mar 5, 2024
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind prostate specific membrane antig...
- Patent number 11,919,956
- Issue date Mar 5, 2024
- Xencor, Inc.
- John R. Desjarlais
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 11,859,011
- Issue date Jan 2, 2024
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted IL-12 heterodimeric Fc-fusion proteins
- Patent number 11,851,466
- Issue date Dec 26, 2023
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibodies that bind to CD38 and CD3
- Patent number 11,840,579
- Issue date Dec 12, 2023
- Xencor, Inc.
- Matthew Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Optimized Fc variants
- Patent number 11,820,830
- Issue date Nov 21, 2023
- Xencor, Inc.
- Gregory Lazar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric proteins
- Patent number 11,814,423
- Issue date Nov 14, 2023
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind CD3 and CLDN6
- Patent number 11,739,144
- Issue date Aug 29, 2023
- Xencor, Inc.
- Matthew S. Faber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Optimized antibody variable regions
- Patent number 11,718,667
- Issue date Aug 8, 2023
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 11,673,972
- Issue date Jun 13, 2023
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IL-12 heterodimeric Fc-fusion proteins
- Patent number 11,655,277
- Issue date May 23, 2023
- Xencor, Inc.
- Matthew Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric proteins
- Patent number 11,634,506
- Issue date Apr 25, 2023
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind CD3 and PSMA
- Patent number 11,623,957
- Issue date Apr 11, 2023
- Xencor, Inc.
- Gregory Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA...
- Patent number 11,618,776
- Issue date Apr 4, 2023
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Optimized antibodies that target CD19
- Patent number 11,618,788
- Issue date Apr 4, 2023
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD28 compositions
- Patent number 11,591,401
- Issue date Feb 28, 2023
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific heterodimeric fusion proteins containing IL-15-IL-15Ralp...
- Patent number 11,584,794
- Issue date Feb 21, 2023
- Xencor, Inc.
- Matthew Bernett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for treating IgE-mediated disorders
- Patent number 11,566,080
- Issue date Jan 31, 2023
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PD-1 targeted heterodimeric fusion proteins containing IL-15/IL-15R...
- Patent number 11,524,991
- Issue date Dec 13, 2022
- Xencor, Inc.
- Matthew Bernett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
IL-7-FC-fusion proteins
- Patent number 11,512,122
- Issue date Nov 29, 2022
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TIM-3 targeted heterodimeric fusion proteins containing IL-15/IL-15...
- Patent number 11,505,595
- Issue date Nov 22, 2022
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific checkpoint inhibitor antibodies
- Patent number 11,492,407
- Issue date Nov 8, 2022
- Xencor, Inc.
- Matthew Bernett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND PROSTATE SPECIFIC MEMBRANE ANTIG...
- Publication number 20240417466
- Publication date Dec 19, 2024
- Xencor, Inc.
- John R. Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6
- Publication number 20240400675
- Publication date Dec 5, 2024
- Xencor, Inc.
- Matthew S. Faber
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-TSLPR (CRLF2) ANTIBODIES
- Publication number 20240360233
- Publication date Oct 31, 2024
- Board of Regents, The University of Texas System
- Dongxing ZHA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORTHOGONAL MULTIMERIC PROTEINS
- Publication number 20240360220
- Publication date Oct 31, 2024
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fc VARIANTS WITH ALTERED BINDING TO FcRn
- Publication number 20240327508
- Publication date Oct 3, 2024
- Xencor, Inc.
- Aaron Keith Chamberlain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PD-1 TARGETED IL-15/IL-15RALPHA FC FUSION PROTEINS WITH IMPROVED PR...
- Publication number 20240294593
- Publication date Sep 5, 2024
- Genentech, Inc.
- John Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPLEMENT COMPONENT C5 ANTIBODIES
- Publication number 20240279317
- Publication date Aug 22, 2024
- Allergan, Inc.
- Peter C. Baciu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND MSLN AND CD3
- Publication number 20240279356
- Publication date Aug 22, 2024
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIOMARKERS, METHODS, AND COMPOSITIONS FOR TREATING AUTOIMMUNE DISEA...
- Publication number 20240262907
- Publication date Aug 8, 2024
- Xencor, Inc.
- Ying DING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fc VARIANTS WITH ALTERED BINDING TO FcRn
- Publication number 20240239879
- Publication date Jul 18, 2024
- Xencor, Inc.
- Aaron Keith Chamberlain
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6
- Publication number 20240228608
- Publication date Jul 11, 2024
- Xencor, Inc.
- Matthew S. Faber
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-CD28 X ANTI-PSMA ANTIBODIES
- Publication number 20240218082
- Publication date Jul 4, 2024
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL18-FC FUSION PROTEINS
- Publication number 20240166705
- Publication date May 23, 2024
- Xencor, Inc.
- Alex NISTHAL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6
- Publication number 20240132584
- Publication date Apr 25, 2024
- Xencor, Inc.
- Matthew S. Faber
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HETERODIMERIC PROTEINS
- Publication number 20240092871
- Publication date Mar 21, 2024
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD28 X ANTI-TROP2 ANTIBODIES
- Publication number 20240059786
- Publication date Feb 22, 2024
- Xencor, Inc.
- John R. Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LAG-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15...
- Publication number 20240025968
- Publication date Jan 25, 2024
- Xencor, Inc.
- Matthew J. Bernett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OPTIMIZED Fc VARIANTS
- Publication number 20240026023
- Publication date Jan 25, 2024
- Xencor, Inc.
- Gregory Lazar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND...
- Publication number 20240026002
- Publication date Jan 25, 2024
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPTIMIZED ANTIBODY VARIABLE REGIONS
- Publication number 20230399401
- Publication date Dec 14, 2023
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES THAT BIND PD-L1, PD-L2, AND/OR CD28
- Publication number 20230383012
- Publication date Nov 30, 2023
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
- Publication number 20230365717
- Publication date Nov 16, 2023
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD28 X ANTI-MSLN ANTIBODIES
- Publication number 20230340128
- Publication date Oct 26, 2023
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TARGETED HETERODIMERIC FC FUSION PROTEINS CONTAINING IL-15/IL-15RA...
- Publication number 20230340053
- Publication date Oct 26, 2023
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPTIMIZED ANTIBODIES THAT TARGET CD19
- Publication number 20230340144
- Publication date Oct 26, 2023
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TIM-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15...
- Publication number 20230331813
- Publication date Oct 19, 2023
- Xencor, Inc.
- Matthew J. Bernett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-CD28 X ANTI-PSMA ANTIBODIES
- Publication number 20230322961
- Publication date Oct 12, 2023
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LAG-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15...
- Publication number 20230279071
- Publication date Sep 7, 2023
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL HETERODIMERIC PROTEINS
- Publication number 20230279154
- Publication date Sep 7, 2023
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS
- Publication number 20230272114
- Publication date Aug 31, 2023
- Xencor, Inc.
- John R. Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

John Desjarlais

Person

Patents Grantslast 30 patents

Heterodimeric antibodies that bind fibroblast activation protein

Bispecific and monospecific antibodies using novel anti-PD-1 sequences

Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alp...

Heterodimeric antibodies that bind CD3 and CD38

Engineered IL-2 Fc fusion proteins

Heterodimeric antibodies that bind CD3 and tumor antigens

PD-1 targeted IL-15/IL-15Rα Fc fusion proteins with improved proper...

Fc variants with altered binding to FcRn

Anti-CD28 compositions

Heterodimeric antibodies that bind prostate specific membrane antig...

Heterodimeric antibodies that bind CD3 and tumor antigens

Targeted IL-12 heterodimeric Fc-fusion proteins

Bispecific antibodies that bind to CD38 and CD3

Optimized Fc variants

Heterodimeric proteins

Heterodimeric antibodies that bind CD3 and CLDN6

Optimized antibody variable regions

Heterodimeric antibodies that bind CD3 and tumor antigens

IL-12 heterodimeric Fc-fusion proteins

Heterodimeric proteins

Heterodimeric antibodies that bind CD3 and PSMA

Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA...

Optimized antibodies that target CD19

Anti-CD28 compositions

Bispecific heterodimeric fusion proteins containing IL-15-IL-15Ralp...

Compositions and methods for treating IgE-mediated disorders

PD-1 targeted heterodimeric fusion proteins containing IL-15/IL-15R...

IL-7-FC-fusion proteins

TIM-3 targeted heterodimeric fusion proteins containing IL-15/IL-15...

Bispecific checkpoint inhibitor antibodies

Patents Applicationslast 30 patents

HETERODIMERIC ANTIBODIES THAT BIND PROSTATE SPECIFIC MEMBRANE ANTIG...

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6

ANTI-TSLPR (CRLF2) ANTIBODIES

ORTHOGONAL MULTIMERIC PROTEINS

Fc VARIANTS WITH ALTERED BINDING TO FcRn

PD-1 TARGETED IL-15/IL-15RALPHA FC FUSION PROTEINS WITH IMPROVED PR...

COMPLEMENT COMPONENT C5 ANTIBODIES

HETERODIMERIC ANTIBODIES THAT BIND MSLN AND CD3

BIOMARKERS, METHODS, AND COMPOSITIONS FOR TREATING AUTOIMMUNE DISEA...

Fc VARIANTS WITH ALTERED BINDING TO FcRn

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6

ANTI-CD28 X ANTI-PSMA ANTIBODIES

IL18-FC FUSION PROTEINS

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6

HETERODIMERIC PROTEINS

ANTI-CD28 X ANTI-TROP2 ANTIBODIES

LAG-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15...

OPTIMIZED Fc VARIANTS

BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND...

OPTIMIZED ANTIBODY VARIABLE REGIONS

ANTIBODIES THAT BIND PD-L1, PD-L2, AND/OR CD28

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

ANTI-CD28 X ANTI-MSLN ANTIBODIES

TARGETED HETERODIMERIC FC FUSION PROTEINS CONTAINING IL-15/IL-15RA...

OPTIMIZED ANTIBODIES THAT TARGET CD19

TIM-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15...

ANTI-CD28 X ANTI-PSMA ANTIBODIES

LAG-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15...

NOVEL HETERODIMERIC PROTEINS

NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS